Ondansetron Tablet, Film Coated
Product Images NDC 43063-770

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 43063-770). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063770 Label (43063770)

This is a medication warning label with instructions for dosage and storage of Ondansetron tablets. It also includes information on reporting side effects and contacting a doctor for medical advice. The tablets are oval and yellow with organoleptic markings of 8G. Each tablet contains 1mg of Ondansetron hydrochloride dihydrate equivalent to 8 mg of Ondansetron USP. It is meant to be taken multiple times a day. There is also a lot number, expiration date, and contact information for the manufacturer. The last few lines seem to be gibberish and cannot be evaluated.*

FDA Label Image

Structure-base (Structure Base)

FDA Label Image

Structure-hcl (Structure HCl)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.